Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Gastrointestinal Neoplasms
×
Everolimus
×
Clear all
Filters
3
NCT04591431
2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2
Unknown
400 enrolled
NCT01567488
2018-01-03
EVERLAR
Grupo Espanol de Tumores Neuroendocrinos
Phase 2
Completed
43 enrolled